McKesson Corporation vs Marvell Technology Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Marvell Technology Inc trades at $211.5 (market cap $171.11B). The key difference: Marvell Technology Inc is the larger of the two by market cap, and McKesson Corporation pays the higher dividend (0.39%). Which is the better fit depends on your goals.
| MCK | MRVL | |
|---|---|---|
Market Cap | $97.35B | $171.11B |
Sector | Health | Technology |
52-Week High | $995.69 | $316.43 |
52-Week Low | $659.01 | $62.31 |
Enterprise Value | $101.98B | $172.55B |
Dividend Yield | 0.39% | 0.12% |
Trailing returns across standard periods
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →